Neil Bajpayee
About Neil Bajpayee
Neil Bajpayee is a Director of Alliance Management at Kite Pharma, where he has worked since 2022. He has a background in microbiology and pharmacology, holding a B.S. from Penn State University and a Ph.D. from UCLA, and has held various roles in business development and technology transfer.
Current Role at Kite Pharma
Neil Bajpayee serves as the Director of Alliance Management at Kite Pharma, a position he has held since 2022. In this role, he is responsible for managing strategic partnerships and collaborations that support the company's objectives in the biopharmaceutical sector. His expertise in alliance management contributes to the development and commercialization of innovative therapies.
Previous Experience at Kite Pharma
Prior to his current role, Neil Bajpayee worked at Kite Pharma as the Associate Director of Alliance Management from 2020 to 2022. During this time, he focused on enhancing collaboration efforts and optimizing partnership strategies to drive the company's initiatives in cell therapy.
Education and Expertise
Neil Bajpayee earned a Bachelor of Science in Microbiology from Penn State University, where he studied from 2000 to 2004. He furthered his education by obtaining a Ph.D. in Molecular and Medical Pharmacology from the University of California, Los Angeles, completing his studies from 2005 to 2011. His academic background provides a strong foundation for his work in the biopharmaceutical industry.
Career History and Roles
Neil Bajpayee has held various positions throughout his career. He worked at the University of California, Los Angeles in multiple roles, including Marketing & Technology Transfer Analyst, Technology Transfer Officer, and Technology Transfer Associate from 2011 to 2015. He also served as Director of Business Development at Trethera from 2017 to 2018 and as Investment Associate at Kairos Ventures from 2018 to 2020.
Research Experience
Neil Bajpayee gained research experience as a U.S. Department of Energy Research Intern at Brookhaven National Laboratory from 2003 to 2004. This role provided him with valuable insights into scientific research and development processes, which he has applied throughout his career in the biotechnology sector.